|
Novartis AG - Topic profile
Topic profile page for Novartis AG.
This page has aggregated data from forum posts, threads, listings, online discussions, newsgroups, messageboards, and other online sources which contain user generated content for the term: Novartis AG.
Search discussions about novartis ag on BoardReader!
|
Latest threads on novartis ag:
 |
Started 3 weeks, 1 day ago (2008-10-26 22:56:00)
by SkinCare11
|
 |
Started 4 weeks ago (2008-10-21 09:26:00)
by Rob Cos
Recs: 0 07:06 NVS Novartis AG CEO seeks biotechs needing funds, investors - Bloomberg.com (52.15 ) - 21Oct2008 Bloomberg.com reports Novartis AG will tap its "strong cash flow'' to make acquisitions, taking advantage of biotechnology companies' inability to raise capital, said Chief Executive Officer Daniel Vasella. Vasella discussed the Basel, Switzerland-based ...  |
|
|
Started 4 weeks ago (2008-10-21 07:08:00)
by Panco123
Recs: 3 07:06 NVS Novartis AG CEO seeks biotechs needing funds, investors - Bloomberg.com (52.15 ) - 21Oct2008 07:06 NVS Novartis AG CEO seeks biotechs needing funds, investors - Bloomberg.com (52.15 ) Bloomberg.com reports Novartis AG will tap its "strong cash flow'' to make acquisitions, taking advantage of biotechnology companies' inability to raise capital, ... |
 |
Started 1 month, 3 weeks ago (2008-09-23 10:07:00)
by alcear
Updated 23-Sep-08 09:40 ET UpgradesSort alphabetically | Sort by brokers Company Ticker Brokerage Firm Ratings Change Price Target Anadarko Petro APC Stanford Research Hold » Buy $81 Valeant Pharmaceuticals VRX Lazard Capital Sell » Hold Xenoport XNPT Lazard Capital Hold » Buy $56 Novartis AG NVS Credit Suisse Underperform » Neutral DowngradesSort alphabetically | Sort by ... |
 |
Started 2 months, 1 week ago (2008-09-10 23:45:00)
by Lani
mTor is a downstream pathway in her2 + breast cancer and has been stuidied in breast cancer as well: Novartis Cancer Drug Wins U.S. Priority Review An investigational drug from Swiss drugmaker Novartis AG has been granted priority review in the United States as a treatment for advanced kidney cancer. Novartis said on Tuesday that RAD001 or everolimus, which it ... |
|
|
Started 2 months, 3 weeks ago (2008-08-29 09:15:00)
by squiffy2
Teva Pharmaceutical Industries Ltd sued Swiss drugmaker Novartis AG and Momenta Pharmaceuticals Inc on Thursday, accusing them of infringing patents on its multiple sclerosis drug Copaxone. Israel-based Teva had said in July it intended to sue after the Sandoz unit of Novartis applied to U.S. regulators to sell a generic version of the medicine. The lawsuit, filed in U.S. District Court in ... |
 |
Started 20 hours, 45 minutes ago (2008-11-17 20:42:46)
by DewDiligence
Gleevec, Sutent Prevent/Cure Type-1 Diabetes in Mice http://www.reuters.com/article/marketsNews/idINN17 52617220081117 ›Mon Nov 17, 2008 5:26pm EST CHICAGO, Nov 17 (Reuters) - Two popular leukemia drugs, Gleevec and Sutent, kept lab mice from developing type 1 diabetes and put 80 percent of diabetic mice in remission, an international team said on Monday. Both drugs -- Gleevec, or imatinib, made ... |
|
|
Started 21 hours, 34 minutes ago (2008-11-17 19:53:00)
by investor737
Recs: 0 Cancer drugs ( Gleevec and Sutent) halt type 1 diabetes in mice CHICAGO, Nov 17 (Reuters) - Two popular leukemia drugs, Gleevec and Sutent, kept lab mice from developing type 1 diabetes and put 80 percent of diabetic mice in remission , an international team said on Monday. Gleevec, or imatinib , made by Novartis AG and Sutent, or sunitinib , made by ... |
|
|
Started 1 day ago (2008-11-17 17:03:00)
by foolcell
Recs: 1 Re: Novartis analysts meeting Wednesday. From today's WSJ. Looks like it could be very interesting in regard to RNAi. NOVEMBER 16, 2008, 10:22 P.M. ET Novartis to Spotlight Research Update Set for Wednesday on Drug Maker's Progress With Experimental MedicinesBy JEANNE WHALEN Six years ago, Swiss drug giant Novartis AG hired a new head of research and ... |
|
|
Started 3 days, 2 hours ago (2008-11-15 14:48:00)
by keahou
Brian, Agree 100% with Tinker's comments. The EDT division revenue is growing 15-20 annually man may even accelerate as new formulations often extend patent life, so I'm told: http://www.elan.com/EDT/ Just this past week with a 20% of sales take: http://www.businessworld.ie/livenews.htm?a=2345197 A pundits embellishment FWIW: http://www.investorvillage.com/smbd.asp?mb=160& ;... |
|
|
Hot threads on novartis ag:
 |
Started 1 week, 1 day ago (2008-11-09 20:25:00)
by Neurobürger
A closer look at Obama’s transition team By Joe Kishore 7 November 2008 http://www.wsws.org/articles/2008/no...tran-n07.sh tml Barack Obama's transition team is a collection of Washington insiders, former Clinton administration officials, corporate and banking executives, and individuals with roots in the Chicago Democratic Party political machine. The Obama-Biden Transition ... |
 |
Started 5 days, 23 hours ago (2008-11-12 18:01:00)
by lando4209
FDA: No link between bone drugs and heart problems Wednesday November 12, 2008, 1:54 pm EST WASHINGTON (AP) -- Government health officials said Wednesday they have found no clear link between popular bone-strengthening drugs and irregular heart rhythms during an ongoing safety review. The Food and Drug Administration advised doctors and patients to continue ... |
|
|
Started 5 days, 10 hours ago (2008-11-13 06:40:10)
by jbog
Brainstorm at Roche Leads to New Valium-Like Drugs (Update1) By Dermot Doherty Nov. 13 (Bloomberg) -- Vincent Mutel saw so much potential in a new way of tweaking the brain's circuitry that he left a job he'd had for 15 years to bet his future on a start-up. The ability to move fast and take a risk on a hunch in his six-year-old venture, Geneva-based Addex Pharmaceuticals Ltd., is paying off. The... | |
